David Wong

机构：University of Toronto, Wesley Hospital · ORCID：0000-0002-3310-3538

发表论文 213 篇 · 总被引 8313 次 · h-index 37

代表论文

• Racial Disparities in Treatment Initiation and Outcomes of Chronic Hepatitis B Virus Infection in North America (2023 · JAMA Network Open · 被引 23)
• Liver-restricted Type I IFN Signature Precedes Liver Damage in Chronic Hepatitis B Patients Stopping Antiviral Therapy (2024 · The Journal of Immunology · 被引 21)
• IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis B (2023 · Hepatology Communications · 被引 21)
• Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B (2022 · The American Journal of Gastroenterology · 被引 18)
• Addition of PEG‐interferon to long‐term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg‐negative chronic hepatitis B (2024 · Journal of Viral Hepatitis · 被引 16)
• Pembrolizumab and stereotactic body radiotherapy combined in advanced hepatocellular carcinoma post sorafenib – A phase II trial (PEMRAD) (2025 · JHEP Reports · 被引 6)